| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |